Expeditive synthesis of trithiotriazine-cored glycoclusters and inhibition of <i>Pseudomonas aeruginosa</i> biofilm formation by SMADHI, M. et al.
Expeditive synthesis of trithiotriazine-cored
glycoclusters and inhibition of Pseudomonas aeruginosa
biofilm formation
M. Smadhi, S. De Bentzmann, A. Imberty, M. Gingras, R. Abderrahim, P.G.
Goekjian
To cite this version:
M. Smadhi, S. De Bentzmann, A. Imberty, M. Gingras, R. Abderrahim, et al.. Expeditive syn-
thesis of trithiotriazine-cored glycoclusters and inhibition of Pseudomonas aeruginosa biofilm




Submitted on 22 Sep 2014
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de




Expeditive synthesis of trithiotriazine-cored glycoclusters and
inhibition of Pseudomonas aeruginosa biofilm formation
Meriem Smadhi1,2, Sophie de Bentzmann*3, Anne Imberty*4, Marc Gingras5,
Raoudha Abderrahim2 and Peter G. Goekjian*1
Full Research Paper Open Access
Address:
1Laboratoire Chimie Organique 2 Glycochimie, Université de Lyon,
ICBMS, UMR 5246 – CNRS, Université Claude Bernard Lyon 1, Bat.
308 –CPE Lyon, 43 Bd. du 11 Novembre 1918, 69622 Villeurbanne,
France. Fax: +33-4-72448109; Tel: +33-4-72448183, 2Université de
Carthage, Faculté des sciences Bizerte, Tunisie, 3Laboratoire
d'Ingénierie des Systèmes Macromoléculaires, Institut de Biologie
Structurale et Microbiologie, CNRS-Aix Marseille University,
UMR7255, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex 20,
France, 4Centre de Recherches sur les Macromolécules Végétales
(CERMAV), UPR 5301 CNRS et Université Grenoble Alpes, BP53,
38041 Grenoble, France and 5Aix-Marseille Université, CNRS, CINaM
UMR 7325, 163 Avenue de Luminy 13288 Marseille, France
Email:
Sophie de Bentzmann* - bentzman@imm.cnrs.fr; Anne Imberty* -
imberty@cermav.cnrs.fr; Peter G. Goekjian* - goekjian@univ-lyon1.fr
* Corresponding author
Keywords:
antibiotic; biofilm; glycocluster; lectin; multivalency effect; multivalent
glycosystems
Beilstein J. Org. Chem. 2014, 10, 1981–1990.
doi:10.3762/bjoc.10.206
Received: 14 February 2014
Accepted: 30 July 2014
Published: 25 August 2014
This article is part of the Thematic Series "Multivalent glycosystems for
nanoscience".
Guest Editor: B. Turnbull
© 2014 Smadhi et al; licensee Beilstein-Institut.
License and terms: see end of document.
Abstract
Readily accessible, low-valency glycoclusters based on a triazine core bearing D-galactose and L-fucose epitopes are able to inhibit
biofilm formation by Pseudomonas aeruginosa. These multivalent ligands are simple to synthesize, are highly soluble, and can be
either homofunctional or heterofunctional. The galactose-decorated cluster shows good affinity for Pseudomonas aeruginosa lectin
lecA. They are convenient biological probes for investigating the roles of lecA and lecB in biofilm formation.
Introduction
Pseudomonas aeruginosa (PA) is an opportunistic human
pathogen known to cause a variety of hospital-borne infections.
It poses a severe threat to immunocompromised patients, as
well as to those suffering from cystic fibrosis or cancer [1-3]. Its
virulence is largely associated with multi-resistance to antibi-
otics, in particular due to the physical barrier created by
surface-attached biofilms, thus limiting antibiotic penetration
[4-6]. A challenging and useful task is therefore to develop
novel strategies against PA colonies at this late stage of viru-
lence. Among recent approaches, targeting biofilm formation or
P14-62 CERMAV-CNRS
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Figure 1: Previously reported low-valent glycoasterisk α-D-Man ligand based on a persulfurated benzene core [30] and currenly reported β-D-Gal
compound 1.
promoting its dissolution is thus particularly appealing. Because
the formation of PA biofilm is a complex process partly medi-
ated by the D-galactose-specific lectin lecA (PA-IL) [7-10] and
the L-fucose-specific lectin lecB (PA-IIL) [11-13], lectin-carbo-
hydrate interactions can provide a new target for pharmacolog-
ical intervention. Further investigations of the specific func-
tions played by these lectins in PA biofilm formation will
provide useful understanding, and ultimately a means of
prevention of PA virulence. The creative design of glyco-
mimetics that can interfere or can modulate the bioactivity of
these lectins in host recognition and adhesion in biofilm forma-
tion represents an attractive antibacterial strategy, as multiva-
lent carbohydrate motifs on cell surfaces are known to mediate
a broad range of cellular and tissue adhesion processes.
Carbohydrate recognition in biological systems is often based
on the recognition of multiple epitopes through a synergistic
and cooperative effect, called the ‘’glycocluster effect” [14-16].
It has been shown in a number of systems that multivalency
effects can be exploited to obtain high-avidity synthetic ligands
against various types of lectins in the form of glycoclusters
[17], poly(glycomer)s [18-21], and glycodendrimers [22-24]. In
regards to PA, C-fucosylpeptide dendrimers were shown to
inhibit biofilm formation and to efficiently disperse established
biofilms in both reference and hospital strains of PA [25-27].
Recently, galactosylated peptide dendrimers have shown a
strong affinity for lecA while inhibiting or dispersing biofilms
[28,29]. This anti-biofilm effect mediated by glycodendrimers
validates a new approach to the control PA propagation and
infection.
In this work and following those lines, we had in mind to
develop simpler, lower molecular weight, and hydrosoluble
multivalent ligands against lecA and lecB, able to exert useful
biofilm inhibition and to provide useful tools for investigating
the roles of lecA and lecB in the colonization process. Our
investigations further aimed at concentrating a high density of
proximate carbohydrate epitopes with limited degrees of
freedom onto a sulfurated heteroaromatic scaffold as novel
glycosylated asterisk ligands [30]. We have thus designed a
simple, yet effective new family of multivalent glycosylated
architectures built around a trithiotriazine core. Both homo- and
heterobifunctional ligands are obtained by a straightforward
preparative route, as an innovative approach. Additionally,
isothermal titration calorimetry (ITC) and dynamic light scat-
tering (DLS) helped to better understand lectin–ligand interac-




A previous study from our laboratories [30] has shown that low-
valent glycoasterisk ligands based on a persulfurated benzene
core [31,32] could have a dual role as a probe and as a ligand,
due to their phosphorescence [33] and electrochemical prop-
erties [34] (Figure 1). They were also highly potent lectin
Beilstein J. Org. Chem. 2014, 10, 1981–1990.
1983
Scheme 1: Synthesis of trivalent trithiotriazine-based glycoclusters.
aggregators. Among other aromatic glycoasterisks, Roy et al.
described the synthesis of densely substituted hexaphenylben-
zene glycoclusters [35].
In this work, we have designed a new family of low-valent
glycoclusters based on a heteroaromatic core with the benefit of
sulfur chemistry [36]. Sulfur facilitates the synthesis by
providing a strong nucleophile and access to a thioether linkage
under mild conditions, but it also enhances a number of poten-
tially useful physical properties. For instance, polysulfuration of
an aromatic core is known to significantly modify the
HOMO–LUMO orbital energies, and thus change the redox
potentials [31-34]. It also shifts the spectroscopic absorption
and emission wavelengths and can lead to a phosphosrescence
emission [33]. Additionally, an aza-aromatic core would
improve water solubility by modifying π–π-interactions and by
favoring hydrogen-bonding to water. These compounds also
lack the hydrophobic peripheral benzene units of the previous
glycoasterisk ligands. They were replaced with a methylene-
triazole linker in order to increase water solubility and to modu-
late the degree of flexibility.
Synthesis of ligands
The glycoclusters were prepared from the inexpensive trithio-
cyanuric acid (1,3-5-triazine-2,4,6-trithiol) as the heteroaro-
matic core (Scheme 1). Trisubstitution of the commercial
trisodium salt with propargyl bromide ensured the facile prepar-
ation of 2,4,6-tris(propargylthio)-1,3,5-triazine (2) as a key
Beilstein J. Org. Chem. 2014, 10, 1981–1990.
1984
precursor [37]. The glycosyl units were incorporated via Cu(I)-
catalyzed Huisgen cycloaddition with protected or unprotected
glycosyl azides.
We first investigated the Cu-catalyzed azide–alkyne cycloaddi-
tion (CuAAC) of acetyl protected β-D-galactopyranosyl azide 3
[38], to tris(propargylthio)triazine 2, using CuI and diisopropy-
lethylamine (DIPEA) in DMF under microwave irradiation at
110 °C for 15 min. It provided the peracetylated D-galactopy-
anosyl cluster 9 in 73% yield. The peracetyl D-glucopyranosyl
cluster 10 was similarly obtained in 92% yield.
The deacetylation of the carbohydrate units proved to be prob-
lematic, as a result of the instability of the triazine system under
either forcing or mild Zemplén deprotection conditions. The
tert-butyldimethylsilyl-protected galactopyranosyl azide 5 was
therefore prepared via the epoxidation of silylated D-galactal
with dimethyldioxirane (DMDO) generated in situ in the pres-
ence of a phase-transfer catalyst, followed by treatment with
NaN3 [39]. This afforded the silyl-protected D-galactose trithio-
triazine–triazole glycocluster 11 under CuSO4/sodium ascor-
bate-catalyzed cycloaddition conditions [40] (20 °C, 24 h), in a
satisfactory 87% yield. The benzyl protected D-glucose glyco-
cluster 12 was similarly prepared from tri-O-benzyl-β-D-
glucopyranosyl azide 6 [39] in 92% yield. The removal of the
silyl groups with TBAF led to complete degradation of the
scaffold. Ammonium fluoride in THF or trifluoroacetic acid
also led to the fragmentation of the cluster core, which
preceded complete deprotection of the carbohydrate groups. We
were unable to obtain the deprotected glycoclusters by this
route.
We therefore investigated a direct route to the glycoasterisks
using unprotected azidosugars, thus avoiding the final deprotec-
tion step. The unprotected azidosugars were obtained by
straightforward deprotection of the corresponding acetyl-
protected azides [38]. The trivalent glycoclusters decorated with
D-galactose, 1, D-glucose, 13, and L-fucose, 14, epitopes were
thus obtained directly in 53%, 50%, and 44% yields, respective-
ly, after reversed-phase chromatography. Methyl 6-azido-6-
deoxy-α-D-mannoside was similarly coupled as a less expen-
sive isostere of L-fucose [41]. The tris 6-C-(6-deoxy-D-
mannosyl) cluster 15 was thus obtained in 47% yield. The
cycloaddition conditions were optimized using 3.3 equiv of
glycosyl azide [39] and one equivalent of tris(propargylthio)-
triazine 2 in DMF, catalyzed by CuI and DIPEA under
microwave irradiation. The incorporation of three carbohydrate
residues was established unambiguously by ESIMS, 1H NMR,
13C NMR, and HMBC analysis, in particular based on the
symmetry of the molecule, and on the lack of signals corres-
ponding to the residual alkynes in the NMR and MS. The
connectivity was established thanks to HMBC 3J proton–carbon
correlations between the anomeric proton of the sugar and the
triazole methine carbon (H-1–C-d), between the trizaole
methine carbon and the thiomethylene protons (C-d–H-b), and
between the thiomethylene protons and the triazine carbon
(H-b–C-a). Despite the moderate yields, these products are
readily accessible, being easy to purify, simple to characterize,
and able to be produced on a relatively large scale.
The current process also offers the possibility of synthesizing
mixed glycoclusters. Reducing the number of equivalents of
glycosyl azide 7 to 2 equiv in the presence of CuI and DIPEA in
DMF at 110 °C under microwave irradiation provided a statis-
tical mixture with the bivalent cluster as the major product. The
bis-D-galactosyl cluster 16 was thus isolated in 34% yield. A
second [3 + 2] cycloaddition with a different glycoside,
such as D-glycopyranosyl azide 8, under the same conditions,
provided for example the mixed Gal2-Glc triazine cluster 17
(Scheme 2).
The efficient conjugation of unprotected glycosyl azides to
trithiotriazine 2 thus provides convenient access to low valency
mono- or heterobifunctional glycoclusters. As expected, they
display excellent aqueous solubility due of the combination of a
dendritic polyheterocyclic architecture and carbohydrate
epitopes.
Biophysical studies
Dynamic light scattering experiments (DLS) were performed on
the trivalent and divalent galactose-substituted clusters 1, 16
and 17, as well as the glucose-substituted cluster 13 as a nega-
tive control. The results show that of the four clusters, only the
divalent bis-D-Gal propargyl cluster 16 induces rapid aggrega-
tion of lecA (Figure 2 and Supporting Information File 1).
Although such results should not be over-interpreted, they
confirm that two epitopes are sufficient for aggregation, and
suggest that additional hydrophobic and hydrophilic interac-
tions play a role. The inability of these systems to efficiently
aggregate lectins is in stark contrast to the hexavalent benzene
cluster [30], which may be attributed to differences in rigidity
and hydrophobicity between the two systems [25]. It thus
appears that the direct diaryl sulfide bridge presents a more
optimal degree of semi-rigidity.
The affinities of the designed glycoconjugates with lecA and
lecB were determined by isothermal titration calorimetry (ITC)
by addition of the ligands to a solution of lectin (Figure 3).
Dissociation constants (Kd) and thermodynamic parameters
(ΔG, ΔH, −TΔS) are listed in Table 1, together with the experi-
mental binding stoichiometry (n), defined as the number of
glycocluster ligands per monomer of lectin.
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Scheme 2: Synthesis of mixed triazine-based glycoclusters.
Figure 2: Dynamic light scattering experiments of bis-D-galactosyl proparyl cluster 16 with lecA. Distribution by mass for lecA + buffer (left) and
lecA + 16 (200 μM, right) at 3 minute intervals. Additional experiments can be found in Supporting Information File 1.
The trivalent tris-galacosylated glycoconjugate 1 displays a
good affinity and a Kd value of 1.09 µM, compared to 94 µM
for the monovalent reference, methyl β-D-galactoside (Table 1).
The stoichiometry indicates that each cluster binds to three lecA
sites. The tris-glucosylated cluster 13 was used as a negative
control with nearly identical physical properties, and showed no
affinity for the lectin, confirming that the recognition is epitope-
specific. The bivalent clusters containing two galactose residues
16 and 17 have similar binding constants, although the mixed
cluster 17 containing two D-galactose and one D-glucose
residues provided better ITC titration curves and more rational
n values than the bis D-galactosyl monopropargyl cluster 16,
Beilstein J. Org. Chem. 2014, 10, 1981–1990.
1986
Figure 3: Typical ITC measurements representing the raw ITC data (top) and integrated titration curves (bottom) for the binding to lecA of a) tris-D-
galactosyl triazine cluster 1, and b) tris D-glucosyl glycocluster 13 (negative control).
Table 1: Thermodynamic parameters of glycoclusters upon binding to lecA by ITCa.









β-D-GalOMed 1 0.8 −42.8 19.8 −23.0 94 1
Gal3-tzn, 1 3 0.31 −66.0 31.9 −34.1 1.09 29
Gal2Glc-tzn, 17 2 0.54 −51.0 19.7 −31.3 3.4 14
Gal2Pg-tzn, 16 2 0.79 −47.6 17.2 −30.5 4.4 11
Glc3-tzn, 13 3 <0
aT = 298 K. bStoichiometry. cImprovement in affinity relative to the methyl glycoside, divided by the valency. dData from reference [50]. Pg =
propargyl; tzn = tris(triazolylmehylthio)triazine.
which may reflect precipitation of the lectin-cluster complex
during the ITC experiment in the latter case, based on the DLS
results above.
The observed β/N values in Table 1, which reflect the relative
affinity per unit sugar, are 29 for the trivalent cluster and in the
range of 12 for the bivalent clusters. These values most likely
reflect sub-site binding by the heterocyclic rings. Indeed, the
divalent clusters 16 and 17 show a relatively less unfavorable
entropy contribution, compared to methyl β-D-galactopyra-
noside, which is consistent with the contribution of additional
hydrophobic interactions. No chelate binding is expected in this
first generation cluster, as the arm length is well below the 29 Å
distance between sugar binding sites [7]. Not unexpectedly,
several reported multivalent clusters have achieved higher
affinities, yet the values observed here fall within the range
obtained with far more complex multivalent systems [28,42-
50]. The β-fucoside-containing trivalent cluster 14 was also
tested by ITC and a Kd of 50 μM was obtained, which is signifi-
cantly higher than the Kd for α-MeFuc (0.43 μM) [41] (data not
shown). This confirms that lecB has lower affinity for β-fuco-
sides than for the α-anomers, but the trimeric β-fucoside cluster
14 still demonstrated reasonable binding. The 6-deoxymannose
isostere 15 was not tested, in view of the low affinity of the
Beilstein J. Org. Chem. 2014, 10, 1981–1990.
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Figure 4: Inhibition of PAO1 biofilm formation by D-galactose cluster 1, L-fucose cluster 14, and D-glucose cluster 13 (negative control). A) Biofilm
growth assay in LB medium. B) Statistical analysis (above, n = 5, duplicate UV measurements) of ethanol-solubilized biofilm recovered from each well
(below). C) PAO1 growth inhibition control test.
β-fucose epitopes. These clusters thus represent a readily acces-
sible, highly soluble, and convenient tool for the investigation
of the role of lecA and lecB in the formation of biofilms by
Pseudomonas aeruginosa.
Inhibition of biofilm formation
While the expectation that glycoclusters with high affinity to
lecA and lecB should inhibit biofilm formation is now a
common design hypothesis, it is nonetheless important to show
whether individual synthetic clusters do so in fact. This has only
been done in a limited number of examples [9,10], perhaps due
to lack of solubility, lack of availability, or other reasons. The
response of PA biofilms to different clusters is not necessarily
directly correlated to their affinity, as many other factors may
intervene, and the accumulation of biofilm data will therefore
be an important factor in our understanding of this complex
process.
The P. aeruginosa adherence assay was performed in 24 well
microplates. Biofilms were obtained after 24 h of incubation at
30 °C in LB medium alone or in the presence or galactose,
fucose, or glucose (control)-substituted trivalent clusters and
stained with crystal violet (CV).
A statistically significant reduction in biofilm formation was
observed at 5 mM concentration of either the galactose- or the
fucose-bearing cluster, 1 and 14, respectively, as compared to
the glucose-bearing cluster, 13, or absence of cluster (Figure 4).
To check that differences observed were not due to bacterial
growth defect in the presence of clusters, a growth inhibition
control experiment was performed (Figure 4C). No growth
defect was observed, further confirming that observed reduc-
tion of biofilm formation in the presence of the galactose or the
fucose-bearing clusters is due to potential effects on P. aerugi-
nosa lectins.
Conclusion
We have developed a convenient synthesis of simple, low-
valency glycoclusters. These compounds have good solubility,
are readily accessible, and are easy to purify and to characterize.
The presence of the sulfur provides beneficial structural and
synthetic elements, and the heterocyclic systems improve solu-
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bility and may potentially lead to better pharmacodynamic
properties for eventual biological applications. They show good
affinities for the lectins, comparable to more complex multiva-
lent systems. The recognition is sugar-specific, as the corres-
ponding D-glucose glycocluster shows no affinity for the lectin,
and can thus be used as a negative control. Both the D-galac-
tose and L-fucose clusters are able to inhibit biofilm formation.
These compounds therefore provide convenient tools for further




1,3,5-triazine (1). A solution of compound 2 (22 mg,
0.073 mmol, 1 equiv), β-D-galactopyranosyl azide (59.7 mg,
0.294 mmol, 4 equiv), CuI (0.022 mmol, 4.2 mg, 0.3 equiv) and
DIPEA (0.2 mL, 15 equiv) in DMF (2 mL) was heated under
microwave irradiation for 15 minutes at 110 °C. The reaction
mixture was concentrated in vacuo and the residue was purified
by C18 chromatography (Combiflash, Grace Reveleris C18 RP
4g Cartridge, H2O/MeOH gradient). Yield = 53%. TLC (C18;
MeOH/H2O 1:1). Rf = 0.42. [α]D +14.5 (c 1, H2O); IR (neat) υ
= 3287.6 cm−1 (OH) 1474.3 (triazole); 1H NMR (400 MHz,
DMSO-d6) δ 8.20 ppm (s, 3H, H-d), 5.45 (d, J = 9.2 Hz, 3H,
H-1), 5.22 (d, J = 6.0 Hz, 3H, OH-2), 5.01 (d, J = 5.7 Hz, 3H,
OH-3), 4.69 (t, 3H, OH-6), 4.64 (d, J = 5.4 Hz, 3H, OH-4), 4.52
(s, 6H, H-b), 4.01 (ddd, J = 9.3 Hz, J = 9.2 Hz, J = 6.0 Hz, 3H,
H-2), 3.76 (br dd, J = 5.7, 3.4 Hz, 3H, H-4), 3.69 (br dd, J =
6.1, J = 6.1 Hz, 3H, H-5), 3.55–3.44 (m, 9H, H-3, H-6, H-6’);
13C NMR (100 MHz, DMSO-d6) δ 178.5 ppm (C-a), 142.4
(C-c), 122.5 (C-d), 88.1 (C-1), 78.4 (C-5), 73.6(C-3), 69.2
(C-2), 68.4 (C-4), 60.4 (C-6), 24.6 (C-b); HRMS–ESI (m/z): [M
+ H]+ calcd for C30H43N12O15S3, 907.2170; found, 907.2127;
(m/z): [M + Na]+ calcd for C30H43N12NaO15S3, 929.1980;
found, 929.1947.
2,4,6-tris(1-(β-D-glucopyranosyl)triazol-4-ylmethylthio)-
1,3,5-triazine (13). A solution of compound 2 (18.1 mg,
0.062 mmol, 1 equiv), β-D-glucopyranosyl azide (51 mg,
0.25 mmol, 4 equiv), CuI (3.5 mg, 0.3 equiv) and DIPEA
(0.74 mmol, 0.16 mL, 15 equiv) in DMF (1 mL) was heated
under microwave irradiation for 15 minutes at 110 °C. The
reaction mixture was concentrated in vacuo and the residue was
purified by C18 chromatography (Combiflash, Grace Reveleris
C18 RP 4g Cartridge, H2O/MeOH gradient). Yield = 50%. TLC
(C18; MeOH/H2O 1:1). Rf = 0.47. [α]D −2.0 (c 0.46, H2O); 1H
NMR (300 MHz, DMSO-d6) δ 8.25 ppm (s, 3H, H-d), 5.51 (d, J
= 9.3Hz, 3H, H-1), 5.38 (d, J = 6.0Hz, 3H, OH-2), 5.27 (d, J =
4.9, 3H, OH-3), 5.14 (d, J = 5.5, 3H, OH-4), 4.63 (t, J = 5.6,
3H, OH-6), 4.52 (s, 6H, H-b), 3.77–3.66 (m, 6H, H-2, H-6),
3.46–3.32 (m, 6H, H-3, H-5, H-6’), 3.25–3.15 (m, 3H, H-4);
13C NMR (75 MHz, DMSO-d6) δ 178.6ppm (C-a), 142.4 (C-c),
122.9 (C-d), 87.5 (C-1), 79.9 (C-3), 76.9 (C-5), 72.0 (C-2), 69.5
(C-4), 60.7 (C-6), 24.6 (C-b); HRMS–ESI (m/z): [M + H]+
calcd for C30H43N12O15S3, 907.2132; found, 907.2127; (m/z):
[M + Na]+ calcd for C30H43N12NaO15S3. 929.1943; found,
929.1947.
2,4,6-tris(1-(β-L-fucopyranosyl)triazol-4-ylmethylthio)-
1,3,5-triazine (14). Compound 2 (132.9 mg, 0.458 mmol,
1 equiv), β-L-fucopyranosyl azide (345.6 mg, 1.82 mmol,
4 equiv), CuI (26 mg, 0.13 mmol, 0.3 equiv) and DIPEA
(1.13 mL, 16.8 mmol, 5 equiv) in DMF (2 mL) was heated
under microwave irradiation for 15 minutes at 110 °C. The
reaction mixture was concentrated in vacuo and the residue was
purified by C18 chromatography (Combiflash, Grace Reveleris
C18 RP 4g Cartridge, H2O/MeOH gradient). Yield = 44%. TLC
(C18; MeOH/H2O 1:1) Rf = 0.5. [α]D +5.2 (c 0.17; H2O); 1H
NMR (400 MHz, DMSO-d6) δ 8.18 ppm (s, 3H, H-d), 5.44 (d, J
= 9.2 Hz, 3H, H-1), 5.22 (d, J = 6.0 Hz, 3H, OH-2), 5.00 (d, J
= 5.5 Hz, 3H, OH-3), 4.70 (d, J = 5.4 Hz, 3H, OH-4), 4.52 (s,
6H, H-b), 4.03–3.94 (m, 3H, H-2), 3.88 (br. q, J = 6.3 Hz, 3H,
H-5), 3.57–3.51 (m, 6H, H-4, H-3), 1.13 (d, J = 6.4 Hz, 9H,
CH3); 13C NMR (100 MHz, DMSO-d6) δ 178.1ppm (C-a),
142.0 (C-c), 122.0 (C-d), 87.6 (C-1), 73.6 (C-3), 73.0 (C-5),
71.0 (C-4), 68.5 (C-2), 24.3 (C-b), 16.3 (CH3); HRMS–ESI (m/
z): [M + H]+ calcd for C30H43N12O12S3, 859.2299; found,
859.2280 ; (m/z): [M + Na]+ calcd for C30H42N12NaO12S3,
881.2096; found, 881.2099.
2,4-bis(1-(β-D-galactopyranosyl)triazol-4-ylmethylthio)-6-
(prop-2-ynylthio)-1,3,5-triazine (16). A solution of compound
2 (35.9 mg, 0.123 mmol, 1 equiv), β-D-galactopyranosyl azide
(50.6 mg, 0.240 mmol, 2 equiv), CuI (0.036 mmol, 7 mg,
0.3 equiv) and DIPEA (1.84 mmol, 0.32 mL, 15 equiv) in DMF
(2 mL) was heated under microwave irradiation for 15 minutes
at 110 °C. The reaction mixture was concentrated in vacuo and
the residue was purified by C18 chromatography (Combiflash,
Grace Reveleris C18 RP 4g Cartridge, H2O/MeOH gradient).
Yield = 34%. [α]D +4.3 (c 0.36, H2O); 1H NMR (400 MHz,
DMSO-d6) δ 8.18 ppm (s, 2H, H-d), 5.44 (d, J = 9.2 Hz, 2H,
H-1), 5.23 (d, J = 6.0 Hz, 2H, OH-2), 5.02 (d, J = 5.6 Hz, 2H,
OH-3), 4.70 (t, J = 5.6 Hz, 2H, OH-6), 4.67 (d, J = 5.3 Hz, 2H,
OH-4), 4.58–4.50 (AB, J ~ 15.0 Hz, 4H, H-b), 4.05–4.03 (m,
2H, H-e), 4.0 (ddd, J = 9.3 Hz, J = 9.2 Hz, J = 6.0 Hz, 2H,
H-2), 3.76 (br dd, J = 5.3 Hz, J = 3.5 Hz, 2H, H-4), 3.69 (br t, J
= 6.0 Hz, 2H, H-5), 3.54–3.46 (m, 6H, H-3, H-6, H-6’), 3.23 (t,
J = 2.5 Hz, 1H, H-g);13C NMR (100 MHz, DMSO-d6) δ 178.4
ppm (C-a), 177.8 (C-a’), 142.4 (C-c), 122.3 (C-d), 87.9 (C-1),
79.5 (C-f), 78.2 (C-5), 73.8 (C-g), 73.4 (C-3), 69.1 (C-2), 68.3
(C-4), 60.2 (C-6), 24.4 (C-b), 18.4 (C-e); HRMS–ESI (m/z): [M
+ H]+ calcd for C24H32N9O10S3, 702.1461; found, 702.1429;
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triazine (17). A solution of the bis-Gal triazine cluster 16
(12.2 mg, 0.017 mmol, 1 equiv), β-D-glucopyranosyl azide
(5.3 mg, 0.026 mmol, 1.5 equiv), CuI (1 mg, 0.3 equiv) and
DIPEA (0.043 mL, 15 equiv) in DMF (1mL) was heated under
microwave irradiation for 15 minutes at 110 °C. The reaction
mixture was concentrated in vacuo and the residue was purified
by C18 chromatography (Combiflash, Grace Reveleris C18 RP
4g Cartridge, H2O/MeOH gradient). Yield = 30%. [α]D −1.2 (c
0.1, H2O); 1H NMR (500 MHz, D2O) δ 8.20 ppm (s, 2H, Gal
H-d), 8.16 (s, 1H, Glc H-d), 5.70 (d, J = 9.2 Hz, 1H, Glc H-1),
5.65 (d, 2H, J = 9.2 Hz, Gal H-1), 4.40 (s, 6H, H-b), 4.19 (t, J =
9.5 Hz, 2H, Gal H-2), 4.09 (d, J = 3.2 Hz, 2H, Gal H-5),
4.01–3.94 (m, 3H, Gal H-4,Glc H-2), 3.88 (dd, J = 9.3 Hz, J =
3.2 Hz, 2H, Gal H-3), 3.77 (d, J = 12.1 Hz, 2H, Gal H-6), 3.76
(d, J = 12.1 Hz, 2H, Gal H-6’), 3.74 (d, J = 11.6 Hz, 1H, Glc
H-6), 3.73 (d, J = 11.6 Hz, 1H, Glc H-6’), 3.71–3.67 (m, 2H,
Glc H-3, Glc H-4), 3.62 (t, J = 9.4 Hz, 1H, Glc H-5); 13C NMR
(125 MHz, D2O) δ 178.7 ppm (C-a), 144.4 (C-c), 123.4 (C-d),
87.1 (Gal C-1), 87.4 (Glc C-1), 78.9 (Glc C-4), 78.3 (Gal C-4),
75.9 (Glc C-3), 73.0 (Gal C-3), 72.3 (Glc C-2), 69.8 (Glc C-5),
68.6 (Gal C-5), 62.5 (Glc C-6), 60.8 (Gal C-6), 24.4 (Cb);
HRMS–ESI (m/z): [M + Na]+ calcd for C30H42N12NaO15S3,
929.1916; found, 929.1947.
Supporting Information
Full 1D and 2D NMR spectra of compounds 1, 2, and 9–17;
experimental procedures for ITC and biofilm inhibition
studies, and for the synthesis of tris propargyl precursor 2,
protected clusters 9–12, and 6-C-mannose cluster 15;
additional DLS and ITC spectra, additional biofilm
quantification information.
Supporting Information File 1
Experimental procedures, characterization checklist and
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